-
GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing
prnasia
November 25, 2021
GreenLight Biosciences (Nasdaq: ENVI), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Environmental Impact Acquisition Corp...
-
Covaxin shows 50 per cent effectiveness against symptomatic COVID in real-world assessment: Lancet study
ExpressPharma
November 25, 2021
Two doses of Covaxin are 50 per cent effective against symptomatic COVID-19, according to the first real-world assessment of India’s indigenous coronavirus vaccine published in The Lancet Infectious Diseases journal.
-
Johnson & Johnson COVID-19 Vaccine Fully Approved by Health Canada to Prevent COVID-19 in Individuals 18 years and Older
AmericanPharmaceuticalReview
November 25, 2021
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that Health Canada has approved its single-shot COVID-19 vaccine to prevent COVID-19 in individuals 18 years of age and older.
-
Some Republicans Calling for 'Natural Immunity' Exception to COVID Vaccines
Drugs
November 25, 2021
Republican lawmakers in several states are pushing vaccine mandate exemptions for workers who have so-called natural immunity due to a previous COVID-19 infection.
-
Vaccibody rebrands to Nykode and bags $925m deal with Regeneron
Pharmaceutical-Technology
November 25, 2021
Norwegian vaccine and immunotherapy-focused biopharma Nykode Therapeutics started off in 2007 as Vaccibody, before rebranding this week to signal its significant growth and transformation plans.
-
Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum
prnasia
November 24, 2021
Seegene Inc. (KQ 096530), a leading biotechnology firm specializing in molecular diagnostics (MDx) has announced financial results for the third quarter ended September 30, 2021.
-
Nykode Therapeutics partners with Regeneron to develop cancer and infectious disease vaccines
PharmaTimes
November 24, 2021
Nykode Therapeutics, a clinical-stage biopharmaceutical company, announced that it has entered into a collaboration agreement with Regeneron.
-
Valneva Inks APA with European Commission for COVID Vax
ContractPharma
November 24, 2021
Valneva SE, a specialty Vaccine company, has signed an Advance Purchase Agreement (APA) with the European Commission (EC) to supply up to 60 million doses of its inactivated COVID-19 vaccine candidate...
-
SII urges govt to fast-track movement of increasing Covishield stock
ExpressPharma
November 24, 2021
The Serum Institute of India (SII) has urged the government to fast-track Covishield movement citing the difficulties being faced in production and cold chain space planning for other vaccines...
-
No scientific evidence to support need for booster vaccine dose against COVID, says ICMR chief
ExpressPharma
November 24, 2021
There is no scientific evidence so far to support the need for a booster vaccine dose against COVID-19, Dr Balram Bhargava, Director General, ICMR, said recently underlining the completion of second dose...